{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:45:21Z","timestamp":1761842721398},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1006\/clim.2000.4924","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"146-153","source":"Crossref","is-referenced-by-count":65,"title":["Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment C"],"prefix":"10.1006","volume":"97","author":[{"given":"Carol O.","family":"Tacket","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Galen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Losonsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L.","family":"Wyant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Nataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven S.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Chatfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2000.4924_RF1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI112899","article-title":"Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans","volume":"79","author":"Levine","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clim.2000.4924_RF2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/151.3.482","article-title":"Demonstration of specific IgA in human feces after immunization with line Ty21a Salmonella typhi vaccine","volume":"151","author":"Cancellieri","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.2000.4924_RF5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/IAI.60.5.2023-2029.1992","article-title":"Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine","volume":"60","author":"Forrest","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF6","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.155.8.3987","article-title":"Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans","volume":"155","author":"Sztein","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2000.4924_RF7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/infdis\/170.6.1508","article-title":"Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi","volume":"170","author":"Sztein","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.2000.4924_RF8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt0892-888","article-title":"Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine","volume":"10","author":"Chatfield","year":"1992","journal-title":"Biotechnology"},{"key":"10.1006\/clim.2000.4924_RF9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0264-410X(96)00227-7","article-title":"A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to foreign antigens","volume":"15","author":"Galen","year":"1997","journal-title":"Vaccine"},{"key":"10.1006\/clim.2000.4924_RF10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/0264-410X(95)00094-H","article-title":"Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain","volume":"13","author":"Gomez-Duarte","year":"1995","journal-title":"Vaccine"},{"key":"10.1006\/clim.2000.4924_RF11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.68.1.205-213.2000","article-title":"In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella typhi as live mucosal vaccines and as live vectors","volume":"68","author":"Pickett","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(89)92033-3","article-title":"Effect of priming with carrier on response to conjugate vaccine","volume":"ii","author":"DiJohn","year":"1989","journal-title":"Lancet"},{"key":"10.1006\/clim.2000.4924_RF13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/IAI.67.3.1338-1346.1999","article-title":"Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF14","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1128\/IAI.67.12.6424-6433.1999","article-title":"Optimization of plasmid maintenance in the attenuated live vector vaccine Salmonella typhi strain CVD 908-htrA","volume":"67","author":"Galen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/IAI.67.10.5133-5141.1999","article-title":"Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium","volume":"67","author":"Dunstan","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF16","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1128\/IAI.66.7.3080-3087.1998","article-title":"Oral vaccination against tetaus: Comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters","volume":"66","author":"Roberts","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4924_RF17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)79439-3","article-title":"Optimism over vaccines administered via mucosal surfaces","volume":"351","author":"Levine","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/clim.2000.4924_RF18","first-page":"801","article-title":"Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing words: Model based regional estimates","volume":"77","author":"Kane","year":"1999","journal-title":"Bull. World Health Org."},{"key":"10.1006\/clim.2000.4924_RF19","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and non-infected adults in Mali","volume":"76","author":"Perry","year":"1998","journal-title":"Bull. World Health Org."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661600949246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661600949246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T20:15:28Z","timestamp":1680552928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661600949246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S1521661600949246"],"URL":"https:\/\/doi.org\/10.1006\/clim.2000.4924","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}